Daniel Fourmy

3.7k total citations
93 papers, 3.1k citations indexed

About

Daniel Fourmy is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, Daniel Fourmy has authored 93 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Cellular and Molecular Neuroscience, 61 papers in Molecular Biology and 33 papers in Oncology. Recurrent topics in Daniel Fourmy's work include Neuropeptides and Animal Physiology (62 papers), Receptor Mechanisms and Signaling (43 papers) and Peptidase Inhibition and Analysis (24 papers). Daniel Fourmy is often cited by papers focused on Neuropeptides and Animal Physiology (62 papers), Receptor Mechanisms and Signaling (43 papers) and Peptidase Inhibition and Analysis (24 papers). Daniel Fourmy collaborates with scholars based in France, Germany and Spain. Daniel Fourmy's co-authors include Marlène Dufresne, Catherine Seva, Chantal Escrieut, Lucien Pradayrol, Véronique Gigoux, Nicole Vaysse, Sandrine Silvente‐Poirot, Pascal Clerc, Luis Moroder and Bernard Maigret and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Physiological Reviews.

In The Last Decade

Daniel Fourmy

92 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Fourmy France 34 1.6k 1.4k 680 604 417 93 3.1k
Pei‐Hua Lu China 38 2.0k 1.2× 837 0.6× 392 0.6× 607 1.0× 331 0.8× 137 4.3k
Peter Thorn Australia 35 2.2k 1.3× 716 0.5× 1.1k 1.7× 192 0.3× 83 0.2× 110 3.8k
Janka Held‐Feindt Germany 41 1.8k 1.1× 492 0.3× 228 0.3× 1.5k 2.5× 409 1.0× 115 4.7k
Kazuki Sasaki Japan 33 1.6k 1.0× 515 0.4× 466 0.7× 513 0.8× 141 0.3× 184 3.4k
Burkhard Wiesner Germany 40 3.3k 2.0× 632 0.4× 231 0.3× 412 0.7× 90 0.2× 103 5.0k
Alex N. Eberlé Switzerland 38 2.1k 1.3× 703 0.5× 133 0.2× 655 1.1× 516 1.2× 161 4.8k
Donald R. Menick United States 36 2.8k 1.7× 906 0.6× 648 1.0× 430 0.7× 127 0.3× 93 4.2k
Gábor Halmos United States 41 1.8k 1.1× 710 0.5× 198 0.3× 1.8k 3.0× 1.1k 2.6× 163 5.0k
Matthias Eckhardt Germany 41 3.5k 2.1× 901 0.6× 604 0.9× 489 0.8× 289 0.7× 103 6.0k
Stuart Walbridge United States 38 1.4k 0.8× 583 0.4× 145 0.2× 520 0.9× 351 0.8× 69 3.6k

Countries citing papers authored by Daniel Fourmy

Since Specialization
Citations

This map shows the geographic impact of Daniel Fourmy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Fourmy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Fourmy more than expected).

Fields of papers citing papers by Daniel Fourmy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Fourmy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Fourmy. The network helps show where Daniel Fourmy may publish in the future.

Co-authorship network of co-authors of Daniel Fourmy

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Fourmy. A scholar is included among the top collaborators of Daniel Fourmy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Fourmy. Daniel Fourmy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clerc, Pascal, et al.. (2018). Combined Treatments of Magnetic Intra-Lysosomal Hyperthermia with Doxorubicin Promotes Synergistic Anti-Tumoral Activity. Nanomaterials. 8(7). 468–468. 9 indexed citations
2.
Clerc, Pascal, Michel Gougeon, Bernard Pipy, et al.. (2017). Targeted Magnetic Intra-Lysosomal Hyperthermia produces lysosomal reactive oxygen species and causes Caspase-1 dependent cell death. Journal of Controlled Release. 270. 120–134. 91 indexed citations
3.
Cordomí, Arnau, Daniel Fourmy, & Irina G. Tikhonova. (2016). Gut hormone GPCRs: structure, function, drug discovery. Current Opinion in Pharmacology. 31. 63–67. 9 indexed citations
4.
Gigoux, Véronique & Daniel Fourmy. (2013). Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPER. Frontiers in Endocrinology. 4. 50–50. 16 indexed citations
5.
Waser, Beatrice, et al.. (2011). Glucose-Dependent Insulinotropic Polypeptide Receptors in Most Gastroenteropancreatic and Bronchial Neuroendocrine Tumors. The Journal of Clinical Endocrinology & Metabolism. 97(2). 482–488. 41 indexed citations
6.
Dufresne, Marlène, Pascal Clerc, M Dieng, et al.. (2010). Id3 modulates cellular localization of bHLH Ptf1‐p48 protein. International Journal of Cancer. 129(2). 295–306. 10 indexed citations
7.
Masri, Bernard, et al.. (2010). Regulation of Membrane Cholecystokinin-2 Receptor by Agonists Enables Classification of Partial Agonists as Biased Agonists. Journal of Biological Chemistry. 286(8). 6707–6719. 15 indexed citations
8.
Marco, Esther, et al.. (2008). Linking Non-peptide Ligand Binding Mode to Activity at the Human Cholecystokinin-2 Receptor. Journal of Biological Chemistry. 283(51). 35860–35868. 11 indexed citations
9.
Tikhonova, Irina G., et al.. (2007). Validated Ligand Binding Sites in CCK Receptors. Next Step: Computer-Aided Design of Novel CCK Ligands. Current Topics in Medicinal Chemistry. 7(12). 1243–1247. 8 indexed citations
10.
Tikhonova, Irina G., Cyril Boulègue, Ingrid Langer, & Daniel Fourmy. (2006). Modeled structure of the whole regulator G-protein signaling-2. Biochemical and Biophysical Research Communications. 341(3). 715–720. 8 indexed citations
11.
Langer, Ingrid, Irina G. Tikhonova, Marie‐Agnès Travers, et al.. (2005). Evidence That Interspecies Polymorphism in the Human and Rat Cholecystokinin Receptor-2 Affects Structure of the Binding Site for the Endogenous Agonist Cholecystokinin. Journal of Biological Chemistry. 280(23). 22198–22204. 25 indexed citations
12.
Tassa, Amina, Audrey Ferrand, Jean‐Pierre Estève, et al.. (2004). The G‐protein‐coupled CCK2 receptor associates with phospholipase Cγ1. FEBS Letters. 568(1-3). 89–93. 13 indexed citations
13.
Ferrand, Audrey, Aline Kowalski‐Chauvel, Lucien Pradayrol, et al.. (2004). Involvement of JAK2 upstream of the PI 3-kinase in cell–cell adhesion regulation by gastrin. Experimental Cell Research. 301(2). 128–138. 37 indexed citations
14.
Clerc, Pascal, Timothy C. Wang, Graham J. Dockray, et al.. (2002). Expression of CCK2 receptors in the murine pancreas: Proliferation, transdifferentiation of acinar cells, and neoplasia. Gastroenterology. 122(2). 428–437. 64 indexed citations
15.
Bierkamp, Christiane, et al.. (2002). Gastrin mediated cholecystokinin-2 receptor activation induces loss of cell adhesion and scattering in epithelial MDCK cells. Oncogene. 21(50). 7656–7670. 32 indexed citations
16.
Escrieut, Chantal, et al.. (1999). Benzotriazonine as a new core structure for the design of CCK-receptor antagonists. Journal of Peptide Science. 5(3). 155–158. 3 indexed citations
17.
Gigoux, Véronique, Chantal Escrieut, Jean‐Alain Fehrentz, et al.. (1999). Arginine 336 and Asparagine 333 of the Human Cholecystokinin-A Receptor Binding Site Interact with the Penultimate Aspartic Acid and the C-terminal Amide of Cholecystokinin. Journal of Biological Chemistry. 274(29). 20457–20464. 67 indexed citations
18.
Gigoux, Véronique, Chantal Escrieut, Sandrine Silvente‐Poirot, et al.. (1998). Met-195 of the Cholecystokinin-A Receptor Interacts with the Sulfated Tyrosine of Cholecystokinin and Is Crucial for Receptor Transition to High Affinity State. Journal of Biological Chemistry. 273(23). 14380–14386. 71 indexed citations
19.
Silvente‐Poirot, Sandrine, Marlène Dufresne, Nicole Vaysse, & Daniel Fourmy. (1993). The peripheral cholecystokinin receptors. European Journal of Biochemistry. 215(3). 513–529. 111 indexed citations
20.
Robberecht, Patrick, Philippe De Neef, Magalì Waelbroeck, et al.. (1988). Secretin Receptors in Human Pancreatic Membranes. Pancreas. 3(5). 529–535. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pei‐Hua Lu Breakdown of academic impact, for papers by Peter Thorn Breakdown of academic impact, for papers by Janka Held‐Feindt Breakdown of academic impact, for papers by Kazuki Sasaki Breakdown of academic impact, for papers by Burkhard Wiesner Breakdown of academic impact, for papers by Alex N. Eberlé Breakdown of academic impact, for papers by Donald R. Menick Breakdown of academic impact, for papers by Gábor Halmos Breakdown of academic impact, for papers by Matthias Eckhardt Breakdown of academic impact, for papers by Stuart Walbridge
Rankless by CCL
2026